Background. Endothelial dysfunction is an important factor in the pathogenesis of atherosclerosis, and endothelial microparticles (EMPs) are considered as markers of endothelial dysfunction. In this study, we aimed to examine the relationship between EMPs and arterial stiffness and atherosclerosis in children with chronic kidney disease (CKD). Methods. This cross-sectional study included 37 dialysis patients (12 haemodialysis, 25 peritoneal dialysis), 33 predialysis patients and 18 healthy controls. Both in vivo and in vitro (HUVECs) evaluations were used for the study. Circulating EMPs were measured by flow cytometry. The carotid artery intima-media thickness (cIMT) and pulse wave velocity (PWV) were measured by using high-resolution ultrasound. Study groups were compared for circulating EMP, cIMT and PWV. The relationship between EMPs and arterial stiffness and atherosclerosis was evaluated. Results. The levels of PWV, cIMT, CD144 + EMP and CD146 + EMP in the dialysis group were significantly higher than those in the pre-dialysis and control groups (P < 0.05). Additionally, the levels of cIMT, CD144 + EMP and CD146 + EMP in the pre-dialysis group were significantly higher than those in the control group (P < 0.05). In all CKD patients, the CD144 + EMP was significantly positively associated with blood pressures, age, known duration of disease, CRP and PTH, and was significantly negatively associated with haemoglobin, GFR and albumin. The CD146 + EMP was significantly positively associated with blood pressures, age and CRP. In a multiple linear regression analysis, in the CKD group, cIMT was independently related to mean blood pressure and dialysis duration. PWV was independently related to the CD144 + EMP and mean blood pressure. Conclusion. Our results suggest that endothelial damage starts in the early stage of CKD, that the endothelial dysfunction becomes overt with the increase of cardiovascular risk factors and that EMPs may be a reliable marker of the subclinical atherosclerosis and arterial stiffness.
Introduction
Cardiovascular disease is one of the most frequent causes of mortality and morbidity in adults and children with chronic renal failure. Increased arterial stiffness and atherosclerosis in patients with end-stage renal failure (ESRD) are strong independent predictors of all-cause and mainly cardiovascular mortality [1] . Endothelial dysfunction is thought to be a key initial event in the development of atherosclerosis and it is believed that endothelial dysfunction develops at the earliest stages of kidney disease when glomerular filtration rate (GFR) begins to fall and blood pressure rises [2] . The presence of endothelial dysfunction may serve as a marker of an unfavourable cardiovascular prognosis [3] . Prolonged or exaggerated endothelial activation by pathophysiological stimuli or agonists such as proinflammatory cytokines, growth factors, infectious agents, lipoproteins and oxidative stress may lead to endothelial dysfunction, an early, preclinical component of vascular disease, and to an irreversible loss of integrity with cell detachment, apoptosis and necrosis [4] .
Cells undergoing apoptosis partially transform into phosphatidylserine-containing apoptotic bodies. Apoptotic bodies are approximately in the size range of a platelet (1-4 µm) [5] . Endothelial microparticles (EMPs) are small (<1.5 µm) vesicular fragments of the endothelial cell membrane released during activation or apoptosis and considered as markers of endothelial dysfunction [4, 6, 7] . Vascular endothelial (VE)-cadherin (CD144) is a strictly endothelial specific adhesion molecule located at junctions between endothelial cells. VE-cadherin regulates various cellular processes such as cell proliferation and apoptosis and modulates VE growth factor receptor functions [8] . The S-Endo 1-associated antigen (CD146) is an integral 2512 I. Dursun et al. membrane glycoprotein belonging to the immunoglobulin superfamily and has been localized to the cell-cell junction in all endothelial cells [9] . So, CD144 and CD146 may be used to evaluate the VE cell damage. Increased EMPs levels have been shown in various diseases such as preeclampsia [10] , diabetes [11] , acute coronary syndrome [12, 13] , severe hypertension [14] , multiple sclerosis [15] and vasculitis [16] . Furthermore, it has been reported that there are increased circulating EMPs in adults with chronic kidney disease (CKD) [17, 18] . To our knowledge, circulating EMPs have not been studied in children with CKD.
In this study, we aimed to investigate the presence of arterial stiffness, atherosclerosis and some risk factors for cardiovascular disease, to examine the relationship between EMP and arterial stiffness and atherosclerosis in children with CKD.
Materials and methods

Patients
This cross-sectional study included 37 dialysis patients (12 haemodialysis, 25 peritoneal dialysis), 33 pre-dialysis patients and 18 healthy controls.
The local institutional ethics committee approved the study protocol. Informed consent was obtained from all subjects. Causes of CKD were obstructive uropathy in 20 children, reflux nephropathy in 9 children, neurogenic bladder in 9 children, cystic renal disease in 5 children, amyloidosis in 4 children, cystinosis in 3 children, urolithiasis in 2 children, polyarteritis nodosa in 2 children, unknown in 9 children and other renal disorders in 7 children. Peritoneal dialysis (PD) and haemodialysis (HD) patients had all undergone regular dialysis treatment for more than 3 months.
Systolic (SBP) and diastolic (DBP) blood pressures were measured at the time of vascular studies by auscultation with an aneroid sphygmomanometer after 15 min in a recumbent position. The non-fistula arm in HD children was used for blood pressure measurement. In addition, mean blood pressure (MBP) was calculated according to the following formula: MBP = DBP+ (SBP − DBP)/3. Anthropometric and ultrasonographic measurements were performed after drainage of peritoneal fluid in PD patients and after dialysis session in HD patients. Body mass index (BMI) was calculated according to the following formula: BMI = weight (kg)/height (m 2 ).
The GFR was estimated by the Schwartz formula [19] , and the patients with GFR <60 ml/min/1.73 m 2 in the pre-dialysis group were included in the study. The duration of the disease was defined as the time between diagnosis of CKD and enrolment into the study.
Laboratory measurements
Blood samples were taken after an overnight fast. Blood samples from HD patients were obtained before the dialysis session. Routine laboratory tests [haemoglobin, serum creatinine, blood urea nitrogen, calcium, phosphorus, intact parathyroid hormone (PTH), fasting lipid profile, C-reactive protein (CRP)] in all patients were immediately performed by an autoanalyser. The serum samples were separated and stored at −80 • C until determination of serum lipoprotein (a) [Lp(a)]. The serum Lp(a) levels were determined by the immunoturbidimetric assay. In the control group, the levels of haemoglobin and Lp(a) were measured.
Sonographic evaluations
The non-invasive assessment of arterial stiffness was evaluated by using aortic pulse wave velocity (aPWV) [20, 21] . The carotid artery intimamedia thickness (cIMT) was also measured as an indicator of atherosclerosis [22] . All assessments were performed by using ultrasonic diagnosis equipment (Power Vision 6000, Toshiba SSA-370A, Japan) and a linear 7.5-MHz transducer. A skilled paediatric radiologist who was unaware of the clinical data examined all the patients consecutively. All measurements were performed with the patient in the supine position in quiet after 5 min of resting. After placing electrodes for three-lead orthogonal ECG, the examination was performed in the order of cIMT and aPWV and completed in 30-45 min for each patient.
Measurement of aPWV.
The bulbous portions of the left carotid artery and left main femoral artery 1 cm proximal to the bifurcation were marked as reference points, and the Doppler spectrum of the arterial flow was determined from these two points. After getting at least five clear and identical waveforms of the heart cycle, the delay time between the peak of the R-wave of the ECG and the beginning of the inclination of the systolic velocity peak was measured from three different cycles and their arithmetical mean was used for the calculations. Carotid to femoral transit time was calculated mathematically by subtracting the delay time of the femoral artery from the delay time of the carotid artery. The carotidfemoral distance was measured manually with a tape over the surface of the body. For calculating PWV of the aorta, the formula 'PWV (m/s) = carotid-femoral distance (m)/carotid-femoral transit time (s)' was used [20, 21] .
Measurement of cIMT. The sonographic measurement of cIMT was performed as previously described [22] . Briefly, on a longitudinal, two-dimensional US image of the carotid artery, the posterior wall of the carotid artery was displayed as two bright white lines separated by a hypoechogenic space. The distance between the leading edge of the first bright line of the far wall (lumen interface) and the leading edge of the second bright line (media-adventitia interface) indicated the IMT. The IMT was measured in the far (deeper) wall of the left distal common carotid artery. The left carotid artery segment 1 cm proximal to the bifurcation was regarded as the reference for measurements. When an optimal image was obtained, it was frozen on the R-wave of the ECG and at least five measurements were performed. After excluding the maximum and minimum values, the arithmetical average of the remaining three measurements was calculated automatically and used for the statistical analysis.
Endothelial microparticles
Blood samples were obtained from PD and pre-dialysis patients during the routine outpatient visit. In HD patients, the non-fistula arm was used for obtaining the blood samples, before the midweek dialysis session. The blood samples were drawn in 0.129 mol/l sodium citrate tubes. Plateletfree plasma (PFP) was prepared as previously described [18] . The samples were centrifuged for 15 min at 1500 g, and plasma was then harvested and centrifuged for 2 min at 13000 g. PFP was stored at −80 • C until used.
Endothelial cell culture
Human umbilical vein endothelial cells (HUVEC) were obtained from the umbilical cord vein by collagenase digestion as previously described [23] . The cells were seeded on gelatin-coated culture plates and grown in the DMEM medium under the standard cell culture conditions (humidified atmosphere, 5% CO 2 , 37 • C). The cells were then detached with a 0.05% trypsin-0.02% EDTA solution and subcultured to the second passage until confluence. All cells were used after two passages.
Incubation of uraemic plasma with HUVEC
When confluent monolayers were established, 20% PFP (patients or control) in the medium was added to each plate containing confluent monolayers, and the cells were cultivated for 24 h as previously described [15] . Fifty microlitres of each supernatant were used.
Labelling of samples for cytometry
Numeration of EMPs was performed using anti-CD144 (VE-cadherin) or anti-CD146 labelling. For the direct assay of patient and control plasma samples, after thawing, 50 µl PFP was incubated with 10 µl anti-CD144-PE (Beckman Coulter, LOT no. 04) and their corresponding IgG isotypematched controls (Beckman Coulter, LOT no. 09). After a 15-min incubation at room temperature, the samples were diluted in a 500 µl binding buffer (Beckman Coulter). Then, 50 µl of Flow count beads (Beckman Coulter, LOT no. 754803) were added to each sample for calculation of EMPs' absolute value. For the assay of cell culture supernatants, 50 µl of each supernatant was incubated with 10 µl anti-CD146-PE (Beckman Coulter, LOT no. 03) and their corresponding IgG isotype-matched controls (Beckman Coulter, LOT no. 09). After a 15-min incubation at room temperature, the samples were diluted in a 500 µl binding buffer (Beckman Coulter). Then, 50 µl of Flow count beads (Beckman Coulter, LOT no. 754803) were added. 
Flow cytometric measurement of EMP
Analyses were performed on a Coulter EPICS XL flow cytometer (Beckman Coulter) by an independent examiner who was unaware of the subject status. Samples' analysis was stopped after the count of 20 000 events at medium flow rate setting as previously performed [17] . Results were expressed as the number of CD144-positive EMP per microlitre of plasma and CD146-positive EMP per microlitre of supernatant ( Figure 1 ).
Statistical analysis
All tests were performed using SPSS for Windows 15.0 and Sigma Stat 3.1. First, the distributions of all parameters were determined by using the Shapiro-Wilk test. The parameters with normal distribution were expressed as mean ± SD, and the parameters with abnormal distribution were expressed as median (minimum-maximum). Comparisons of means were performed with Student's t-test. Comparisons of medians were performed with the Mann-Whitney U-test. Comparisons of proportions were performed with the chi-squared test. The comparisons between the three groups for the parameters with normal distribution were done using ANOVA with the post hoc Tukey procedure, and for the parameters with abnormal distribution were done using the Kruskal-Wallis H-test. Then, when a statistical significant was found in Kruskal-Wallis H-test, Dunn's procedure was done. Correlations were calculated with the Pearson product moment or Spearman rank order, as determined by the normalcy of data distribution. Two multiple regression analyses were performed. The first multiple regression analysis, using a stepwise method in the CKD group, was performed with cIMT as a dependent variable and MBP, duration of dialysis, CRP, CD144 + EMP, age, GFR and albumin as independent variables. The second multiple regression analysis in the CKD group was performed by using a stepwise method with PWV as a dependent variable and MBP, CRP, CD144 + EMP, age, GFR, albumin and PTH as independent variables. A P-value of <0.05 was accepted as statistically significant.
Results
Demographic, clinical and anthropometric data are displayed in Table 1 , and biochemical characteristics, EMPs results and vascular measurements data are displayed in Table 2 for the three study groups.
PWV and cIMT are increased in uraemic children
The mean aortic PWV in the dialysis group was higher than that in the pre-dialysis and control groups (P < 0.05). There was no difference in PWV between the pre-dialysis group and control group ( Table 2 ). The mean aortic PWV in HD was higher than that in the PD patients (P < 0.05, Table 3 ). The mean cIMT in the dialysis group was higher than that in the pre-dialysis and control groups (P < 0.05). In addition, the mean cIMT in the pre-dialysis group was statistically higher than that in the control group (P < 0.05, Table 2 ). The mean cIMT in HD was higher than that in the PD patients (P < 0.05, Table 3 ).
Plasma levels of EMP are increased in children with CKD
Compared with the control group, the whole CKD group displayed higher levels of EMP. CD144 + EMP levels were significantly elevated in the dialysis and predialysis groups compared to control subjects. Furthermore, CD144 + EMP levels in dialysis patients were significantly higher than those in pre-dialysis patients (P < 0.05, Table 2 ). CD144 + EMP levels in the HD group were statistically higher than those in the PD group (P < 0.05, Table 3 ).
Effect of uraemic plasma on HUVEC (in vitro)
. Results of the assay of CD146 + EMP are shown in Table 2 . Uraemic toxins in both dialysis and pre-dialysis patients increased the release of CD146 + EMP in HUVEC compared with the control group (P < 0.05, Table 2 ). CD146 + EMP levels were significantly elevated in the HD group compared to the PD group (P < 0.05, Table 3) .
When a univariate analysis between PWV, cIMT and all study parameters in the CKD group was performed, PWV correlated positively with CD144 + EMP, CD146 + EMP, blood pressures, CRP, PTH and age, and negatively with GFR, albumin and haemoglobin. On the other hand, cIMT correlated positively with CD144 + EMP, CD146 + EMP, blood pressures, duration of dialysis and disease, CRP, PTH and age, and negatively with GFR, albumin and haemoglobin (Table 4) . When a univariate analysis between EMPs and all of study parameters in the CKD group was performed, there were significant positive correlations between CD144 + EMP and blood pressures, duration of disease, CRP, PTH and age, and there were significant negative correlations between CD144 + EMP and GFR, albumin and haemoglobin. There were significant positive correlations between CD146 + EMP and blood pressures, CRP and age (Table 5) . Factors independently associated with cIMT and arterial stiffness were examined by a multiple regression analysis and results were presented in Table 6 . In the CKD group, MBP and duration of dialysis were found to be independent predictors for cIMT (R 2 = 0.474, P = 0.006 and P = 0.05, respectively). CD144 + EMP and MBP were independent predictors of PWV (R 2 = 0.460, P = 0.001 and P = 0.03, respectively) ( Table 6 ).
Discussion
The present study demonstrates that children with CKD have atherosclerosis and arterial stiffness. In addition, circulating EMPs are increased in uraemic children. Moreover, EMPs in the circulation are found to be strongly related with the atherosclerosis and arterial stiffness in present study.
Epidemiological and clinical studies have shown that the functional and structural changes in the large arteries are a major contributing factor for the high cardiovascular mortality of ESRD patients [24] . The effects of uraemia on the vascular structure could be a dramatic increase in arterial stiffness, and early markers of athero-/arteriosclerosis and of a sub-clinical or clinically overt atheromatous disease [25] . Arterial stiffness and atheromatous disease can be assessed non-invasively by measurement of PWV and cIMT, respectively [26] [27] [28] . The measurement of cIMT using high-resolution USG was commonly used for the non-invasive evaluation of carotid atherosclerosis, and the changes in the carotid artery were regarded as a good indicator of systemic atherosclerosis in CKD patients as well as in the general population [29] [30] [31] [32] [33] [34] . There are a lot of studies about the presence of increased cIMT in children with CKD [35] [36] [37] . We previously demonstrated that cIMT in children with CKD was significantly increased compared with healthy controls [38] . In the present study, cIMT was found to be significantly higher in the dialysis group than for pre-dialysis or controls, and cIMT was also higher for the pre-dialysis group compared with controls. The cIMT in the haemodialysis group was found to be significantly higher than that in the peritoneal dialysis group. These findings support the presence of atherosclerosis in our patients' group and are similar to previous studies. There are several studies on the association between cIMT and cardiac risk factors in patients with CKD. In these studies, cIMT was positively correlated with hypertension [37] [38] [39] , lipid abnormalities [40, 41] , Lp(a) [40] , CRP [42] and PTH [36, 43] . cIMT was negatively correlated with albumin [35] . In our study, there were significantly positive correlations between cIMT and blood pressures, circulating EMPs, PWV, age, CRP, duration of dialysis and CKD whereas there were significantly negative correlations between cIMT and albumin, haemoglobin and GFR. MBP was independently related to cIMT in our CKD group when a multiple linear regression analysis was performed, and it was the most important predictor of cIMT in our study. Our data show that there are some risk factors associated with atherosclerosis, which were also found in previous studies; in particular, the high blood pressure was effective on the atherosclerosis formation. These results are in accordance with the literature. Our study results are particularly important to emphasize the effective control of the blood pressure in children with CKD.
Arterial stiffness is an independent risk factor for cardiovascular mortality and morbidity in patients with renal disease [44] . It can be assessed non-invasively by measurement of PWV [24, 36, 45] . Covic et al. [46] found that PWV was significantly higher in children with ESRD on haemodialysis compared with controls. In addition, Wang et al. [47] have shown that aortic PWV is associated with duration of the disease in CKD patients. In a study by Zoungas et al. [48] , in 207 adults with CKD, it was found that increased arterial stiffness (PWV) was an independent, and the most important, predictor of cardiovascular outcomes. In our study, aortic PWV in the dialysis group was significantly higher than that in the pre-dialysis and healthy controls groups. In addition, aortic PWV in the pre-dialysis group was found to be significantly higher than that in the control group. The PWV in the haemodialysis group was found to be statistically significantly higher than that in the peritoneal dialysis group. The last finding may be associated with successful blood pressure control in children continuing on PD. Our study shows that the severity of the renal failure and the modality of dialysis may be effective on arterial stiffness. Several studies have reported the association between aortic stiffness and cardiac risk factors in patients with CKD. In these studies, PWV was positively correlated with hypertension [49, 50] , hyperlipidaemia [51] , CRP [52] and PTH [46] and was negatively correlated with albumin [49] . In the present study, there were significantly positive correlations between blood pressures, circulating EMPs, cIMT, age, CRP and PTH and also there were significantly negative correlations between aortic stiffness and albumin, haemoglobin and GFR. MBP and circulating EMPs were independently related to aortic stiffness in our CKD group when a multiple linear regression analysis was performed. This result was similar to previous studies investigating the relation between aortic stiffness and cardiac risk factors in patients with CKD.
The vascular endothelium provides a strategic barrier between the circulating blood and the tissues. Endothelial dysfunction is thought to be a key initial event in the development of atherosclerosis, a principal mechanism being through a loss or reduction in the effect of the eNO [2] . In a previous study performed in adult CKD patients, it was shown that endothelial dysfunction develops at the earliest stages of renal disease [2] . Prolonged or exaggerated endothelial activation by a uraemic toxin leads to endothelial dysfunction and circulating EMPs detached from a blood vessel [4, 17, 18] . The vascular diseases can cause detectable changes in the composition of EMPs derived from VE cells [53] . The release of EMPs is regulated by the various cardiovascular risk factors causing endothelial dysfunction [53] . Preston et al. [15] found a positive correlation of EMPs with the level of both systolic and diastolic blood pressures. They suggested that EMP could be a determinant reflecting the effect of the blood pressure on the endothelium, and also the high EMP values might contribute to the pathogenesis of the vascular damage in patients with severe hypertension. Recently, two important studies have been published on adult patients with CKD. Faure et al. [18] measured the level of circulating EMP in pre-dialysis patients with CKD and in HD patients and studied the ability of some uraemic toxins to induce EMP release in HUVEC. They found that the levels of CD144 and 146 + EMP in the pre-dialysis and haemodialysis groups were significantly higher than those in the healthy controls and that uraemic toxins significantly increased EMP release by cultured HUVEC. They found no correlation between the EMP number and the blood pressure, albumin and haemoglobin levels. In the other study, Amabile et al. [17] detected similar findings. They also investigated the relationship between circulating EMPs and arterial dysfunction and found that the level of EMPs correlated with the loss of flow-mediated dilatation, increased PWV and an increased carotid artery augmentation index [17] . In our study, the number of circulating EMPs in the dialysis group was significantly higher than that in the pre-dialysis and control groups, and also in the pre-dialysis group was significantly higher than that in the healthy control group. In our study, we showed that cardiovascular risk factors (e.g. blood pressures, PTH, CRP, decreased albumin, anaemia and decreased GFR) caused an increase of EMP. In addition, we found increased EMPs, indicates endothelial dysfunction, in in HD patients compared to PD patients. We think that this finding showes that endothelial dysfunction in PD patients is more slightly than in HD patients. A comparison is not possible since there is not a similar study for children with CKD. The high value of EMP levels in our patients may have pathophysiological effects on the atherosclerotic progression [18] . The increase of EMPs in CKD patients could derive from the increased uraemic toxins, and the increased EMPs may cause changes in the arterial structure [17, 18] .
Our results suggest that the endothelial damage starts in the early stage of CKD, that the endothelial dysfunction becomes overt with the increase of cardiovascular risk factors, that the EMPs may be a reliable marker of the subclinical atherosclerosis and arterial stiffness and that in children on CAPD the cardiovascular indices are more favourable than in those on HD. Although the numbers of patients are small, we could comment that PD is better than HD for children.
In conclusion, cIMT and PWV were found to be increased in children with CKD. MBP is the most important risk factor for atherosclerosis, and also EMPs and MBP are the most important risk factors for arterial stiffness. Multi-centric studies should be performed to use EMP as a determinant in the clinical practice and the normal values should be determined by carrying out measurements on the healthy population.
Introduction
Chronic kidney disease (CKD) is common in heart failure (HF) [1] and is attributable to similar underlying risk factors as well as adverse effects of HF itself on renal function over time [2] . The presence of CKD accelerates the progression of cardiovascular disease and ventricular remodelling to HF and the progression of HF to death [2, 3] . In HF, both the level of CKD and the development of worsening renal function (WRF) during treatment of HF are potently and independently associated with poor outcomes [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] . This is increasingly relevant as the average level of renal
